Google Ventures, formed back in March, has made its first investment into a biotech company, according to Fierce Biotech. The company invested about $13 million into antibody start-up Adimabm, which uses computational approaches to develop its antibody library. Google Venture plans to invest $100 million in biotech in the coming year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.